In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter Spends Big on ApaTech to Join Orthobiologics Fray

Executive Summary

Baxter International Inc. brought its full and considerable weight to bear to the orthobiologics market by paying handsomely for Apatech Inc., a privately held start-up with a silicate substituted calcium phosphate synthetic bone graft material.
Advertisement

Related Content

Are Device VCs Becoming Spineless?
Are Device VCs Becoming Spineless?
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q1 2010
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q1 2010
Bioactive Technologies for Bone Replacement
Medical Device Earn-Outs More Common As Buyers Hedge Bets
Has Orthovita's Fight Finally Ended?
Market in Focus: Surgical Sealants and Glues

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel